Aspirin loading in coronary artery disease patients already taking aspirin: A systematic review

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

Asham Hila; Separham Ahmad; Kamali Mohammad Javad; Faraj Musab Hama; Maleki Mehdi; Mehrpooya Maryam; Sarbakhsh Parvin; Entezari Maleki Taher

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: JOURNAL OF CARDIOVASCULAR AND THORACIC RESEARCH Year:2025 | Volume:17 | Issue:3 Page(s): 145-152

Download Full-Text

View:

Download:

Cites:

Information Journal Paper

Title

Aspirin loading in coronary artery disease patients already taking aspirin: A systematic review

Author(s)

Keywords

Aspirin

Reloading

Coronary artery diseases

Thromboxane B2

Percutaneous coronary intervention

Abstract

Aspirin is considered a cornerstone medication among patients with established coronary artery disease (CAD). There is a lack of evidence regarding aspirin reloading in CAD patients who are already receiving aspirin therapy. We performed this systematic review to address this gap of knowledge. A systematic review on PubMed, Embase, and the Cochrane Library was conducted from inception until July 15, 2024. Two authors independently performed study selection, data extraction, and risk of bias assessment. Means differences (MD) were used in a meta-analysis of related outcomes from the studies. Our review included four studies enrolling 1187 individuals with CAD and chronic aspirin use before admission. The results of this systematic review found that aspirin reloading is significantly associated with a reduction of thromboxane B2 (MD, -17.46; 95% CI, -19.61 to -15.32; P<0.00001; I2=0%). Additionally, our findings revealed the beneficial effects of aspirin loading on thromboxane B2 -related platelet reactivity and myocardial injury indexes. No significant adverse outcomes, such as bleeding and increased mortality, were observed among the study groups. In conclusion, aspirin reloading can improve cardiovascular outcomes with a good safety profile among CAD individuals. However, further randomized clinical trials (RCTs) are still needed to provide robust evidence.

Multimedia

No record.

Cites

No record.

References

No record.

Cite

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans